A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome
about
Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer PreventionPharmaceutical and biomedical applications of affinity chromatography: recent trends and developmentsVariation and quantification among a target set of phosphopeptides in human plasma by multiple reaction monitoring and SWATH-MS2 data-independent acquisitionPreliminary proteomic analysis of human serum from patients with laryngeal carcinoma.Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomyRat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.Application of proteomics to cancer early detectionA xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerSmoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011Modulation of glycan detection on specific glycoproteins by lectin multimerization.Analytical glycobiology at high sensitivity: current approaches and directionsDevelopment of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsIdentification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.High-sensitivity analytical approaches for the structural characterization of glycoproteins.Glycopeptide enrichment and separation for protein glycosylation analysis.Unleashing the power of proteomics to develop blood-based cancer markers.Microbial lectins and their prospective mitogenic potential.Serum proteomics in biomedical research: a systematic review.Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers.Mass spectrometry-based plasma proteomics: state of the art and future outlook.Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Intact glycopeptide characterization using mass spectrometry.Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications.Development of an improved fractionation of the human plasma proteome by a combination of abundant proteins depletion and multi-lectin affinity chromatography.Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.Biomarker discovery and validation: the tide is turning.Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS.Characterization of lectin binding affinities via direct LC-MS profiling: implications for glycopeptide enrichment and separation strategies.High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.Lectins: an effective tool for screening of potential cancer biomarkers.Multiplexed panel of precisely quantified salivary proteins for biomarker assessment.Disparities between immobilized enzyme and solution based digestion of transferrin with trypsin.Glycoprotein electrophoretic patterns have potential to monitor changes associated with neoplastic transformation in oral cancer.Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction.
P2860
Q26784486-9AA2B166-E47A-4446-A19D-A7824BB3C0F8Q27014989-2C8BFF08-A596-43DD-908C-843972B89E75Q30826158-CA02205D-A0CC-4CDB-B339-E931D5396137Q34039085-F6E07A76-F563-4770-A27A-7AAB39A6129AQ34079994-8A0C8119-0C4F-4205-878E-E3A859A2DA2DQ34488550-D1512041-8E6D-40C4-93A5-BB5FECEA1AE7Q34939050-DBD20E2D-3555-4C33-8CE3-3767FC23E954Q35053031-A44C52B6-E7E4-4960-BE86-D97B6DE62AB7Q35736782-7E493222-D0D6-4AA3-A820-C4D4C7F37090Q36362594-C96340BE-9644-467B-98B3-C60A7A136C1EQ36452318-91CF90FD-C5F2-4631-AFBB-BA33B9C78B42Q36589272-73BCD05B-1BE8-42D3-A9C4-0C94AA57E754Q36651493-920EB97D-9A6D-49E5-AA09-584BA60234E8Q36850614-6F3E966F-C035-46B5-880A-926A502BBF6CQ36889137-9AEB70AD-58F0-46E2-83DF-8F14DD53D98BQ37142407-790D96F9-0DA1-4142-9DF9-2FD2A4E026FDQ37712517-315D3E43-D41C-4841-92FA-37570F1E3A6BQ38045258-7A061509-886F-4E42-AFC0-D07ECF1304CAQ38055674-6153BF38-912F-4E08-9E14-AC41044F88CCQ38065207-47024EAF-B13C-4CA1-8D49-44E3FC421EDCQ38101008-81AA7C36-72F1-45F5-A35A-49C12556FA94Q38103831-199FB560-B74C-4108-B425-72E740D9458DQ38198753-17CEE1E2-124C-4316-B23F-AF5CCDB32DADQ38217009-D12D67E1-0485-439B-AB04-F6F0C263A8A0Q38824113-FFC674D7-F31A-456E-B4FA-933585540EA2Q38947233-7AC98665-A2B4-4481-A9DA-9410C06E6EEBQ39095877-4D14A17E-8EA7-4782-B45B-97FB5C85F7E1Q40408281-E68559F3-D0CC-4315-B652-3B8EB9C25BFDQ43608679-3169FB2C-4ADF-4F7A-BF2C-DDB0CA58EF90Q44037318-5BD556CC-ABB0-44DA-9543-44F2425FE660Q46459875-F83D540E-A36D-4449-914C-3315B6559D71Q47336088-5B126534-9621-4287-A395-AC4C90B9CAB7Q47954074-B710164C-12FC-487D-9620-1F2D1EDE8740Q51564069-72A352A7-85E5-410B-8E0B-57692B8D772DQ53126854-45036DC8-C2B7-4E2E-BB51-597436D1C6AFQ53176273-4DC2031E-077C-436B-A5F3-1D60387B2C81Q54949772-3CB02218-AF23-46A7-A4C8-BAC709C670B4Q54962725-238E2043-2160-4D9F-9CBF-109FD4F68B2EQ55386462-D677B8B7-D11D-44CD-AFE3-1E3993EC009F
P2860
A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A proteomics platform combinin ...... udy the breast cancer proteome
@ast
A proteomics platform combinin ...... udy the breast cancer proteome
@en
type
label
A proteomics platform combinin ...... udy the breast cancer proteome
@ast
A proteomics platform combinin ...... udy the breast cancer proteome
@en
prefLabel
A proteomics platform combinin ...... udy the breast cancer proteome
@ast
A proteomics platform combinin ...... udy the breast cancer proteome
@en
P2093
P2860
P356
P1433
P1476
A proteomics platform combinin ...... udy the breast cancer proteome
@en
P2093
Jason M Hogan
Joost Schalkwijk
Marina Hincapie
Samir Hanash
William S Hancock
P2860
P304
P356
10.1021/AC2002802
P407
P577
2011-05-23T00:00:00Z